Clinical Trial Highlights

• BEAUTIFUL Trial Fails to Meet Primary Endpoint
• Intensified Medical Therapy Does Not Appear to Benefit Elderly Heart Failure Patients
• Fish Oil Supplementation—But Not Statin Therapy—Reduces Death in Heart Failure
• Mixed Results with Telmisartan in ACE-Intolerant Patients with Diabetes or High-Risk Vascular Disease
• Extended-Release Fluvastatin is Associated with Improved Cardiac Outcomes after Elective Major Vascular Surgery: Results from DECREASE III
• Coronary Artery Bypass Graft Surgery Superior to Percutaneous Coronary Stenting in Patients with Left Main or Three-Vessel Coronary Disease
• PCI is a “Reasonable” Strategy for Diabetic Patients with Multivessel Disease: The CARDia Trial
• Biodegradable Biolimus Stent Appears Safe and Effective in PCI
• Darapladib May Slow Expansion of Atherosclerotic Plaques
• Promise and Problems Emerge for Oral Investigative Factor Xa Drug in Treating Acute Coronary Syndrome
• Tirofiban Significantly Reduces Myocardial Damage after PCI Compared with Standard Antiplatelet Therapy
• Positive Trends in FIRE Hint at Protection from Reperfusion Injury
• Intensive Lipid-Lowering Therapy with Simvastatin/Ezetimibe Combination Does Not Affect the Progression of Aortic Valve Stenosis: Results from the SEAS Study